Continuous 14 Day Infusional Ifosfamide for Management of Soft-Tissue and Bone Sarcoma: A Single Centre Retrospective Cohort Analysis

Continuous 14 Day Infusional Ifosfamide for Management of Soft-Tissue and Bone Sarcoma: A Single Centre Retrospective Cohort Analysis

Ifosfamide is used to treat soft-tissue sarcoma (STS) and bone sarcoma (BS), with improved efficacy at doses above 9 g/m<sup>2</sup>/cycle. To mitigate treatment-associated toxicity with higher doses, continuous infusional ifosfamide is increasingly used. However, clinical outcome data r...

Full description

Bibliographic Details
Main Authors: Thomas J. Carter, Marina Milic, Joanna McDerra, Anne McTiernan, Mahbubl Ahmed, Vasilios Karavasilis, Maria Michelagnoli, Rachael Windsor, Beatrice Seddon, Jeremy Whelan, Palma Dileo, Sandra J. Strauss
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Cancers
Subjects:
infusional ifosfamide
bone sarcoma
soft-tissue sarcoma
chemotherapy
Online Access:https://www.mdpi.com/2072-6694/12/11/3408

Internet

https://www.mdpi.com/2072-6694/12/11/3408

Similar Items